Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot open-label randomized study of saquinavir/ritonavir monotherapy versus standard HAART
2006-001136-47Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of saquinavir and ritonavir in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Virologic suppression at 24 weeks and Virologic suppression at 48 weeks. Started Apr 2006; status: completed.
02
Drugs
saquinavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-001136-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001136-47.